Breast cancer
Roll of Innate Immune Receptors (TLR) and their agonists in improving chemotherapy response in Triple Negative Breast Cancer Patients.
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
ICMR National Institute For Research In Reproductive HealthMumbaiDirections ↗
Registry summary (technical)
Roll of toll-like receptors and TLR agonists in modulating response to chemotherapy in TNBC patients.
Sponsor: Department of Biotechnology
CTRI/2020/03/023958 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 14 Sep 2026 · read by us 5 Nov 2026